The Heparin Disaster – Heparin Lawsuits
Experienced Defective Drug Attorney Fighting for the Rights of Drug Injury Victims
On February 14, 2008, Zoll & Kranz, LLC became the first law firm in the nation to file suit against Baxter Healthcare Corporation, in addition to other companies associated with contaminated batches of the dangerous drug heparin. Our drug injury firm led the way in pharmaceutical litigation by filing multiple heparin lawsuits in federal court, as well as performing dangerous drug investigations into cases both in and outside of Ohio.
For more information regarding the drug recall of contaminated heparin and subsequent prescription drug litigation, please visit the following links:
Drug Injury Firm Nationally Renowned for Multidistrict Litigation
On May 29, 2008, Zoll & Kranz, LLC argued before the United States Judicial Panel on Multidistrict Litigation (MDL) that the Heparin Products Liability Litigation should be transferred to the Northern District of Ohio, located in Toledo, Ohio, before the Honorable Chief Judge James G. Carr. Baxter Healthcare Corporation, Scientific Protein Laboratories, LLC, as well as other defendants included in the defective drug litigation suggested transferring the MDL to other districts, including:
- Southern District of Illinois
- District of New Jersey
- Southern District of Florida
- District of Puerto Rico
- Northern District of California
However, we were successful in our endeavor. On June 6, 2008, the United States Judicial Panel on Multidistrict Litigation issued a transfer order that relocated the Heparin Multidistrict Litigation MDL No. 1953 to the Northern District of Ohio with Honorable Chief Judge James G. Carr overseeing the proceedings.
Defective Drug Attorney Team at Zoll & Kranz Handles Lawsuits Against Drug Companies
Our law firm was also honored when three of our clients—Leroy Hubley, Colleen Hubley and Johanna Staples—were invited to speak in front of the U.S. House Commerce Committee on Energy and Commerce. One of the oldest standing committees of the U.S. House of Representatives, the Committee on Energy and Commerce hosted a hearing on April 29, 2008, entitled “The Heparin Disaster: Chinese Counterfeits and American Failures.” At the hearing, our clients relayed their experiences with contaminated heparin. Other individuals who attended this hearing included:
- Panel I with witnesses David Nelson, Senior Investigator for the Committee on Energy and Commerce; as well as our clients Colleen Hubley, Leroy Hubley and Johanna Staples
- Panel II witnesses included Janet Woodcock, Director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research; Deborah M. Autor, Director of the FDA’s Office of Compliance; and Regina T. Brown, Consumer Safety Officer of the FDA’s Division of Field Investigations
- Panels III and IV included witnesses Robert Parkinson, CEO and President of Baxter International, Inc.; David Strunce, CEO of Scientific Protein Laboratories; Yan Wang, Ph.D. Vice President of Business Development and Research at Scientific Protein Laboratories; and Clive Meanwell, CEO of The Medicines Company
Contact a Defective Drug Attorney Today
Many individuals affected by the dangerous drug heparin had the right to pursue compensation for drug injuries sustained because of contaminated medication. If you or someone you care about is in a similar situation, it is in your best interest to seek counsel and legal advice regarding your options. Our firm offers a complimentary case evaluation of potential bad drug lawsuits from a wide range of defective drugs and medical devices. To get started, call our MDL and mass tort attorneys at (888) 841-9623 today.